The Xpert Breast Cancer Insight Test Predicts Distant Recurrence and Overall Survival in ER-Positive, HER2-Negative Early Breast Cancer.

Saved in:
Bibliographic Details
Title: The Xpert Breast Cancer Insight Test Predicts Distant Recurrence and Overall Survival in ER-Positive, HER2-Negative Early Breast Cancer.
Authors: Filipits M; Center for Cancer Research, Breast Health Center and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Austrian Breast and Colorectal Cancer Study Group (ABCSG), Vienna, Austria. Electronic address: martin.filipits@meduniwien.ac.at., Gruber V; Center for Cancer Research, Breast Health Center and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Singer CF; Department of Gynecology, Breast Health Center and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Fitzal F; Department of General Surgery, Breast Health Center Hanusch Krankenhaus, Vienna, Austria., Bago-Horvath Z; Department of Pathology, Breast Health Center and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Greil R; Third Medical Department, Paracelsus Medical University Salzburg, Salzburg, Austria., Balic M; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria; Division of Hematology and Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA., Regitnig P; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria., Toro-Bauer N; Department of Surgery, Breast Health Center, Hospital Wiener Neustadt, Wiener Neustadt, Austria., Hulla W; Department of Clinical Pathology and Molecular Pathology, Breast Health Center, Hospital Wiener Neustadt, Wiener Neustadt, Austria., Egle D; Department of Gynecology and Obstetrics, Medical University Innsbruck, Innsbruck., Lizarraga D; Cepheid Inc., Sunnyvale, CA., Baker A; Cepheid Inc., Sunnyvale, CA., Kaldate R; Cepheid Inc., Sunnyvale, CA., Satya M; Cepheid Inc., Sunnyvale, CA., Weidler J; Cepheid Inc., Sunnyvale, CA., Bates M; Cepheid Inc., Sunnyvale, CA., Campbell S; Cepheid Inc., Sunnyvale, CA., Hlauschek D; Austrian Breast and Colorectal Cancer Study Group (ABCSG), Vienna, Austria., Dubsky P; Department of Surgery, Medical University of Vienna, Vienna, Austria; St. Anna Breast Center, Hirslanden Klinik St. Anna, Lucerne, Switzerland., Gnant M; Austrian Breast and Colorectal Cancer Study Group (ABCSG), Vienna, Austria; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Source: Clinical breast cancer [Clin Breast Cancer] 2026 Aug; Vol. 26 (8), pp. 112-120. Date of Electronic Publication: 2026 Jul 24.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1938-0666
DOI:10.1016/j.clbc.2026.06.012